Towards a protein vaccine for nontypeable Haemophilus influenzae

Clinical Infectious Diseases

Volumn 28, Issue 2, 1999, Pages 238-

  Kyd, Jennelle M ^a   Cripps, Allan W ^a  

^a UNIVERSITY OF CANBERRA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; IMMUNE RESPONSE; IMMUNIZATION; INFECTION PREVENTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032970324     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515119     Document Type: Conference Paper

References (3)

1. 1. Kyd JM, Cripps AW. Modulation of antigen-specific T and B cell responses influence bacterial clearance of nontypeable Haemophilus influenzae from the lung in a rat model. Vaccine 1996;14:1471-8.
2. 2. Kyd JM, Cripps AW. Potential of a novel protein, OMP26, from nontypeable Haemophilus influenzae to enhance pulmonary clearance in a rat model. Infect Immun 1998;66:2272-8.
3. 3. Kyd JM, Dunkley ML, Cripps AW. Enhanced respiratory clearance of nontypeable Haemophilus influenzae following mucosal immunization with P6 in a rat model. Infect Immun 1995;63:2931-40.